for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cannabis Science Inc

CBIS.PK

Latest Trade

0.02USD

Change

0.00(+37.10%)

Volume

8,889,579

Today's Range

0.01

 - 

0.02

52 Week Range

0.00

 - 

0.06

As of on the Over The Counter ∙ Minimum 15 minute delay

Pricing

Previous Close
0.01
Open
0.01
Volume
8,889,579
3M AVG Volume
60.63
Today's High
0.02
Today's Low
0.01
52 Week High
0.06
52 Week Low
0.00
Shares Out (MIL)
575.66
Market Cap (MIL)
31.26
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Cannabis Science - Co Successfully Completed Reorganization Of European Business

Gene One Life Science signs contract worth 2.14 bln won

Gene One Life Science signs contract worth 4.23 bln won

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cannabis Science Inc

Cannabis Science, Inc. is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company focuses on the development of governmentally approved pharmaceuticals, including CS-TATI1, CS-S/BCC-1 and neurological therapy under study or development. The Company's subsidiaries include Cannabis Science BV and Cannabis Science International Holding BV.

Industry

Biotechnology & Drugs

Contact Info

19800 Macarthur Blvd Ste 300

+1.888.8890888

https://www.cannabisscience.com/

Executive Leadership

Raymond C. Dabney

President, Chief Executive Officer, Director

Benjamin C.K. Tam

Chief Financial Officer, Secretary, Director

Robert Kane

Chief Operating Officer, Director

Mario Lap

Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
4,434.27
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
-526.03

Latest News

BRIEF-Gene One Life Science to issue 3rd series convertible bonds worth 12 bln won

* Says it will issue 3rd series unregistered and unsecured private convertible bonds, to raise 12 billion won in proceeds for operations

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up